Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Integrin beta 1/CD29 Antibody (MEM-101A), Alexa Fluor™ 405, Novus Biologicals™

Mouse Monoclonal Antibody
Supplier: Novus Biologicals NB500383AF405
Description
Integrin beta 1/CD29 Monoclonal specifically detects Integrin beta 1/CD29 in Human, Porcine, Canine, Mouse (Negative) samples. It is validated for Western Blot, Flow Cytometry.Specifications
Integrin beta 1/CD29 | |
Monoclonal | |
Alexa Fluor 405 | |
P05556 | |
ITGB1 | |
Raji Burkitt's lymphoma cell line Raji (NM_002211.3). | |
0.1 mL | |
Cancer, Cytokine Research, Cytoskeleton Markers, Embryonic Stem Cell Markers, Immunology, Mesenchymal Stem Cell Markers, Neuronal Cell Markers, Neuronal Stem Cell Markers, Phospho Specific, Signal Transduction, Stem Cell Markers | |
3688 | |
Human, Pig, Canine, Mouse (Negative) | |
Purified |
Western Blot, Flow Cytometry | |
MEM-101A | |
Western Blot, Flow Cytometry | |
CD29, CD29 antigen, Fibronectin receptor subunit beta, FNRBVLAB, GPIIA, integrin beta-1, integrin VLA-4 beta subunit, integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includesMDF2, MSK12), MDF2, MSK12, very late activation protein, beta polypeptide, VLA-4 subunit beta, VLA-BETA | |
Mouse | |
Protein A purified | |
RUO | |
Primary | |
The antibody MEM-101A reacts with CD29 (integrin beta1 chain), a 130 kDa single chain type I glycoprotein expressed as a heterodimer (non-covalently associated with the integrin alpha subunits 1-6). CD29 is broadly expressed on majority of hematopoietic and non-hematopoietic cells (leukocytes, platelets, fibroblasts, endothelial cells, epithelial cells and mast cells). HLDA VI; WS Code AS A048 | |
Store at 4C in the dark. | |
IgG1 |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction